Mankind Pharma targets early Semaglutide launch

drug approval expired 85% Health

Mankind Pharma is targeting an early launch of a Semaglutide-based product in India, aiming to compete in the rapidly growing GLP-1 weight loss and diabetes drug market. The move signals intensifying competition in the pharmaceutical sector for this blockbuster drug class.

🇮🇳 Location: IN — Sources: 1 — First seen: — Last seen:
Mankind Pharma Semaglutide GLP-1 pharma launch India

Contributing Articles